AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
Over-the-counter (OTC) inhalers are not approved for treating COPD. Prescription inhalers like short-acting beta 2-agonists (SABAs) are the best for COPD. Using OTC inhalers can hide worsening ...
cRespiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK dDepartment of Pediatrics, University of Colorado ...